arrow
R

Rosemary Sutton

University of New South Wales
H指数:47
被引数:8,790

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Blinatumomab in de novo AYA ALL—Results of the Australasian Leukaemia and Lymphoma Group ALL09 “SUBLIME” study
2026-01-230
OAAI
Measurable residual disease detection in acute lymphoblastic leukaemia: comparison between targeted next-generation sequencing and allele-specific oligonucleotide real-time quantitative polymerase chain reaction

急性淋巴细胞白血病的可测量残留病灶检测:靶向下一代测序与等位基因特异性寡核苷酸实时定量聚合酶链反应的比较

2025-11-250
PRE
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients
2024-07-051
OAAI
The recombinome of IKZF1 deletions in B-cell precursor ALL

B细胞前体ALL中IKZF1缺失的重组组

LEUKEMIA
IF13.4
2023-06-293
PRE
The KMT2A recombinome of acute leukemias in 2023
LEUKEMIA
IF13.4
2023-04-0566
OAAI
Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions
2022-06-015
OA
Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma
2021-09-018
OAAI
Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study
LEUKEMIA
IF13.4
2021-07-0142
OAAI
Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials

高危b细胞前体和T细胞复发急性淋巴细胞白血病患儿的危险因素和结局: ALLR3和all-rez BFM 2002临床试验的联合分析

2021-07-0143
OAAI
Methotrexate-reidted central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemia

甲氨蝶呤引起的中枢神经毒性: 儿童急性淋巴细胞白血病的临床特征,危险因素和全基因组关联研究

2021-02-1123
OAAI
The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia
2020-03-0951
OA
More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling
2019-11-1179
OAAI
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols

根据aeop-bfm方案治疗的ABL类融合阳性b细胞急性淋巴细胞白血病患儿的复发和治疗相关事件对预后不良的贡献相同

2019-10-1036
OAAI